Clinical Trial Update: A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II clinical study evaluating safety, efficacy, and pharmacokinetics/pharmacodynamics of JSKN033 in patients with advanced non-small cell lung cancer; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• JSKN033

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Non Small Cell Lung Cancer (NSCLC) | Phase 2 | Status: NOT_YET_RECRUITING